Treatment of anemia syndrome in children with chronic kidney disease (literature review)
Abstract
Literature review summarizes features of anemia syndrome treatment in children with chronic kidney disease.
About the Authors
E. V. Lysova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
N. D. Savenkova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
References
1. Смирнов А.В., Есаян А.М., Каюков И.Г. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6 (4): 11-17 (Smirnov A.V., Esajan A.M., Kajukov I.G. Hronicheskaja bolezn’ pochek: na puti k edinstvu predstavlenij. Nefrologija 2002; 6 (4): 11-17)
2. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Эпидемиология и социально-экономические аспекты хронической болезни почек. Нефрология 2006; 10 (1): 7-13 [Smirnov A.V., Dobronravov V.A., Kajukov I.G. i dr. Jepidemiologija i social’nojekonomicheskie aspekty hronicheskoj bolezni pochek. Nefrologija 2006; 10 (1): 7-13]
3. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Рекомендации Научно-исследовательского института нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова: определение, классификация, диагностика и основные направления профилактики хронической болезни почек у взрослых. Левша, СПб, 2008; 51 [Smirnov A.V., Dobronravov V.A., Kajukov I.G. i dr. Rekomendacii Nauchno-issledovatel’skogo instituta nefrologii Sankt-Peterburgskogo gosudarstvennogo medicinskogo universiteta im. akad. I.P. Pavlova: opredelenie, klassifikacija, diagnostika i osnovnye napravlenija profilaktiki hronicheskoj bolezni pochek u vzroslyh. Levsha, SPb, 2008; 51]
4. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Проблема модификации классификации хронической болезни почек. Нефрология 2010; 15(2): 7-15 [Smirnov A.V., Dobronravov V.A., I.G. i dr. Problema modifikacii klassifikacii hronicheskoj bolezni pochek. Nefrologija 2010; 15(2): 7-15]
5. Greenbaum L.A. Anemia in Chronic Renal Disease. In: Geary D.F., Schaefer F., eds. Comprehensive pediatric nephrology. Mosby Elsevier, Philadelphia, 2008; 761-772
6. Atkinson M.A., Furth S.L. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7: 635-641
7. Koshy S.M., Geary D.F. Anemia in children with chronic kidney disease. Pediatr Nephrol. 2008; 23: 209-219
8. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Inter. Suppl 2012; 2: 331-335
9. Практические клинические рекомендации KDIGO по анемии при хронической болезни почек 2012. Нефрология и диализ 2012; 15 (1): 14-53 [Prakticheskie klinicheskie rekomendacii KDIGO po anemii pri hronicheskoj bolezni pochek 2012. Nefrologija i dializ. 2012; 15 (1): 14-53]
10. The National Institute for Health and Clinical Excellence (NICE). National costing report: anaemia management in people with CKD. Implementing NICE guidance in England. Issued: February 2011. This updates and replaces NICE clinical guideline 39
11. K/DOQI; National Kidney Foundation III Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Children. Am J Kidney Dis. 2006; 47 (3): 86-108
12. Эттингер О.А., Зеновко И.К., Гендин Т.Е. Анемия при хронической болезни почек: роль препаратов железа. Лечебное дело 2012; 4: 38-46 [Jettinger O.A., Zenovko I.K., Gendin T.E. Anemija pri hronicheskoj bolezni pochek: rol’ preparatov zheleza. Lechebnoe delo 2012; 4: 38-46]
13. Albaramki J., Hodson E.M., Craig J.C., Webster A.C. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012 Jan 18; 1: CD 007857.doi
14. Warady B.A., Kausz A., Lerner G. et al. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 2004; 19 (6): 655-661
15. Rozen-Zvi B., Gafter-Gvili A., Paul M., Leibovici L., Shpilberg O., Gafter U. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis 2008; 52 (5): 897-906
16. Morgan H.E., Holt R.C., Jones C.A., Judd B.A. Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin Pediatr Nephrol 2007; 22 (11): 1963-1965
17. Моисеев С.В. Железа карбоксимальтозат (Феринжект®) - новый внутривенный препарат для лечения железодефицитной анемии. Клиническая фармакология и терапия 2012; 21 (2): 2-7 [Moiseev S.V. Zheleza karboksimal'tozat (Ferinzhekt®) - novyj vnutrivennyj preparat dlja lechenija zhelezodeficitnoj anemii. Klinicheskaja farmakologija i terapija 2012; 21 (2): 2-7]
18. Warady B.A., Zobrist R.H., Finan E. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis. Pediatr Nephrol 2006; 21 (4): 553-560
19. Goldstein S.L., Morris D., Warady B.A. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. Am J Kidney Dis 2013; 61 (4): 588- 597
20. Moorani K.N., Asim S. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease. J Ayub Med Coll Abbottabad 2011; 23 (3): 47-50
21. Van Buren P., Velez R.L., Vaziri N.D., Zhou X.J. Ironoverdose: a contributor to adverse outcomes in randomized trials of anemia correction inCKD. Int Urol Nephrol. 2012; 44 (2): 499-507
22. Geisser Р. The pharmacology and safety profile of ferric carboxymaltose (Ferinject ®): structure/reactivity relationships of iron preparations. Port. J. Nephrol. Hypert 2009 ; 23 (1): 11-16
23. Warady B.A., Zobrist R.H., Wu J., Finan E. Ferrlecit Pediatric Study Group. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol. 2005; 20: 1320-1327
24. Morgan H.E., Gautam M., Geary D.F. Maintenance intravenous iron therapy in pediatric hemodialysis patients. Pediatr Nephrol 2001; 16: 779-783
25. Warady B.A., Silverstein D.M. Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease. Pediatr Nephrol 2014; 29 (9): 1493-1505
26. Bamgbola O.F., Kaskel F.J., Coco M. Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol. 2009; 24: 571-579
27. De Palo T., Giordano M., Palumbo F. et al. Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis. Pediatr Nephrol. 2004; 19 (3): 337-340
28. Шило В.Ю. Новый эритропоэз-стимулирующий препарат Аранесп (дарбэпоэтин альфа) в коррекции анемии почечного генеза Рабочая группа по анемии (РГА); Центр диализа при ГКБ № 20, г. Москва. Нефрология и диализ 2007, 9 (3): 216-223 [Shilo V.Ju. Novyj jeritropojez-stimulirujushhij preparat Aranesp (darbjepojetin al’fa) v korrekcii anemii pochechnogo geneza Rabochaja gruppa po anemii (RGA); Centr dializa pri GKB № 20, g. Moskva. Nefrologija i dializ 2007, 9 (3): 216-223]
29. Schmitt C.P., Nau B., Brummer C., Rosenkranz J., Schaefer F. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients. Nephrol. Dial. Transplant 2006; 21: 3520-3524
30. Hattori M., Uemura O., Hataya H., Ito S., Hisano M., Ohta T., Fujinaga S., Kise T., Gotoh Y., Matsunaga A., Ito N., Akizawa T.; The KRN321 Pediatric Study Group. Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan. Clin Exp Nephrol. 2014; 18 (4): 634- 6 41
31. Can C., Emre S., Bilge I., Yilmaz A., Şirin A. Comparison of recombinant human erythropoietin and darbepoetin alpha in children. Pediatr Int. 2013; 55(3): 296-299
32. Лысова. Е.В., Савенкова Н.Д. Особенности синдрома анемии при хронической болезни почек у детей. Нефрология 2014, 18(3): 34-44 [Lysova. E.V., Savenkova N.D. Osobennosti sindroma anemii pri hronicheskoj bolezni pochek u detej. Nefrologija 2014, 18(3): 34-44]
33. Nangaku M., Eckardt K.U. Hypoxia and the HIF system in kidney disease. J Mol Med.2007; 85(12): 1325-1330
Review
For citations:
Lysova E.V., Savenkova N.D. Treatment of anemia syndrome in children with chronic kidney disease (literature review). Nephrology (Saint-Petersburg). 2015;19(3):20-31. (In Russ.)
Views:
518
Email this article 